Current Report Filing (8-k)
2023年4月26日 - 5:02AM
Edgar (US Regulatory)
0001158780
false
0001158780
2023-04-19
2023-04-19
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): April
19, 2023 (April 25, 2023)
PLURI INC.
(Exact Name of Registrant as Specified in Its Charter)
Nevada |
|
001-31392 |
|
98-0351734 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification No.) |
MATAM Advanced Technology Park |
|
|
Building No. 5 |
|
|
Haifa, Israel |
|
3508409 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
011 972 74 710 7171
(Registrant’s telephone number, including area
code)
(Former name or former address, if changed since last
report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Shares, par value $0.00001 per share |
|
PLUR |
|
The Nasdaq Global Market |
Indicate by check mark whether the registrant is an
emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 3.01. | Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. |
On April 19, 2023, Pluri
Inc. (the “Company”) received a letter (the “Notice”) from The Nasdaq Stock Market (“Nasdaq”)
advising the Company that for 30 consecutive trading days preceding the date of the Notice, the bid price of the Company’s common
shares had closed below the $1.00 per share minimum required for continued listing on the Nasdaq Global Market pursuant to Nasdaq Listing
Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). The Notice has no effect on the listing of the Company’s
common shares at this time, and the Company’s common shares continue to trade on the Nasdaq Global Market under the symbol “PLUR.”
Under Nasdaq Listing
Rule 5810(c)(3)(A), if during the 180 calendar day period following the date of the Notice the closing bid price of the Company’s
common shares is at or above $1.00 for a minimum of 10 consecutive business days, the Company will regain compliance with the Minimum
Bid Price Requirement and its common shares will continue to be eligible for listing on the Nasdaq Global Market, absent noncompliance
with any other requirement for continued listing. The compliance period for the Company to comply with the Minimum Bid Price Requirement
will expire on October 16, 2023 (the “Compliance Period”).
If the Company does
not regain compliance with the Minimum Bid Price Requirement by the end of the Compliance Period, then under Nasdaq Listing Rule 5810(c)(3)(A)(i)
the Company may transfer to The Nasdaq Capital Market, provided that it meets the applicable market value of publicly held shares requirement
for continued listing as well as all other standards for initial listing of its common shares on the Nasdaq Capital Market (other than
the Minimum Bid Price Requirement) and notifies Nasdaq of its intention to cure the deficiency. Following a transfer to The Nasdaq Capital
Market, under Nasdaq Listing Rule 5810(c)(3)(A)(ii), the Company may be afforded an additional 180-days to regain compliance
with the Minimum Bid Price Requirement.
If the Company does
not regain compliance with the Minimum Bid Price Requirement by the end of the Compliance Period (or the Compliance Period as may be extended)
the Company’s common shares will be subject to delisting.
The Company intends
to monitor the closing bid price of its common shares and may, if appropriate, consider implementing available options to regain compliance
with the Minimum Bid Price Requirement under the Nasdaq Listing Rules, including initiating a reverse stock split.
SIGNATURES
Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
PLURI INC. |
|
|
Date: April 25, 2023 |
By: |
/s/ Chen Franco-Yehuda |
|
Name: |
Chen Franco-Yehuda |
|
Title: |
Chief Financial Officer |
Pluristem Therapeutics (NASDAQ:PSTI)
過去 株価チャート
から 12 2024 まで 1 2025
Pluristem Therapeutics (NASDAQ:PSTI)
過去 株価チャート
から 1 2024 まで 1 2025
Real-Time news about Pluristem Therapeutics Inc (ナスダック市場): 0 recent articles
その他のPluri Inc.ニュース記事